...
机译:Cost-Effectiveness Analysis of New Beta-Lactam Beta-Lactamase Inhibitor Antibiotics Versus Colistin for the Treatment of Carbapenem-Resistant Infections
Univ Colorado;
infectious diseases; cost effectiveness; anti-infectives; pharmacoeconomics; ACUTE KIDNEY INJURY; DISEASES SOCIETY; CEFTAZIDIME-AVIBACTAM; RENAL-FAILURE; GUIDELINES; MANAGEMENT; AMERICA; ADULTS;